Development of a penem antibiotic against Mycobacteroides abscessus
Batchelder et al. report a new penem class antibiotic, T405, which exhibits potent activity against M. abscessus and clinical isolates from cystic fibrosis patients. The development of resistance to T405 is inhibited with the addition of a β-lactamase inhibitor, avibactam. Its clinical potential is...
Guardado en:
Autores principales: | Hunter R. Batchelder, Elizabeth Story-Roller, Evan P. Lloyd, Amit Kaushik, Kristina M. Bigelow, Emily C. Maggioncalda, Eric L. Nuermberger, Gyanu Lamichhane, Craig A. Townsend |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e507dd0a49447c7b96b6dc7becd6906 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Designing a multi-epitope vaccine against Mycobacteroides abscessus by pangenome-reverse vaccinology
por: Hamza Arshad Dar, et al.
Publicado: (2021) -
Genome-Wide Essentiality Analysis of
<i>Mycobacterium abscessus</i>
by Saturated Transposon Mutagenesis and Deep Sequencing
por: Dalin Rifat, et al.
Publicado: (2021) -
Global phylogenomic analyses of Mycobacterium abscessus provide context for non cystic fibrosis infections and the evolution of antibiotic resistance
por: Ryan A. Bronson, et al.
Publicado: (2021) -
Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline.
por: Jaryd R Sullivan, et al.
Publicado: (2021) -
The Prophage and Plasmid Mobilome as a Likely Driver of Mycobacterium abscessus Diversity
por: Rebekah M. Dedrick, et al.
Publicado: (2021)